Janoshik Analytics: Why Third-Party Testing Matters for Peptides

When a peptide vendor reports purity, identity, and content data, that information originates from their own quality-control laboratory. While many manufacturers maintain rigorous internal standards, the structural incentive to report favorable results creates a fundamental conflict of interest. Third-party testing eliminates this problem by placing analytical responsibility in the hands of a laboratory that has no financial relationship with the vendor. The resulting data is independent, reproducible, and auditable.

Studies in pharmaceutical quality control have consistently demonstrated that independent verification catches discrepancies that internal QC misses. In the research peptide market, where regulatory oversight is minimal compared to approved pharmaceuticals, the risk of quality discrepancies is significantly higher.

Janoshik Analytics is an independent analytical testing laboratory based in Prague, Czech Republic. The laboratory specializes in the analysis of research compounds, including synthetic peptides, small molecules, and related chemical products. The lab has become one of the most frequently cited independent testing sources in the research peptide community due to its accessibility, rapid turnaround, and transparent reporting.

The laboratory operates analytical instrumentation including HPLC systems with UV-Vis detection, electrospray ionization mass spectrometers (ESI-MS), and complementary techniques for identity and purity determination. Results are provided in standardized report formats that include raw chromatographic data, spectral information, and quantitative assessments.

Independent peptide testing laboratories typically offer a core panel of analytical methods designed to answer three fundamental questions: Is the sample pure? Is the sample the correct compound? What is the actual peptide content?

• Reverse-Phase HPLC (RP-HPLC): Separates the target peptide from impurities based on hydrophobicity. Reports purity as a percentage of total chromatographic peak area at 220 nm UV detection.
• Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms molecular identity by measuring the mass-to-charge ratio of ionized peptide molecules. Observed MW should match theoretical value within plus or minus 1 Da.
• MALDI-TOF Mass Spectrometry: Rapid molecular weight determination particularly suited for larger peptides above 5 kDa.
• UV Spectrophotometry: Quantitative content determination using Beer-Lambert law at characteristic absorption wavelengths.
• Amino Acid Analysis (AAA): Provides definitive compositional verification and net peptide content via complete hydrolysis and chromatographic quantification.

The incentive structure in vendor self-testing creates predictable biases. A manufacturer who discovers that a production batch falls below the advertised purity threshold faces a choice: discard the batch (accepting the financial loss) or adjust analytical parameters to produce a more favorable result. Adjustments might include altering HPLC integration thresholds, selecting optimal injection volumes, or cherry-picking the best sample from a heterogeneous batch.

This does not imply that all vendors manipulate data — many maintain excellent internal QC programs. However, the structural incentive exists regardless of individual integrity. Third-party testing eliminates this dynamic entirely because the testing laboratory has no financial stake in the outcome.

A typical Janoshik analytical report includes: a sample identification section (compound name, lot number, date received), HPLC chromatogram with purity percentage, mass spectrum with observed and theoretical molecular weight, and a summary table. The chromatogram is the most critical piece of raw data — it shows the actual separation of the target peptide from any impurities.

When interpreting results, researchers should verify that the observed molecular weight matches the theoretical value within instrument tolerance. For HPLC data, the purity percentage should be consistent with the vendor claim (within plus or minus 2% is generally acceptable given method variability). Significant deviations indicate a quality problem warranting further investigation.

ISO/IEC 17025:2017 is the international standard for testing and calibration laboratories. Accreditation demonstrates that a laboratory operates a quality management system, maintains technically competent staff, uses validated analytical methods, and produces reliable results. Key requirements include documented measurement uncertainty, regular proficiency testing, traceability of measurements to SI units, and systematic management of non-conforming work.

Not all independent testing laboratories hold ISO 17025 accreditation. Some operate under equivalent quality frameworks or follow Good Laboratory Practice (GLP) guidelines. When selecting a laboratory for peptide verification, researchers should prioritize labs with documented quality systems, transparent method descriptions, and willingness to provide raw data alongside summary reports.

Several independent laboratories serve the research peptide community, each with distinct strengths:

• Janoshik Analytics (Prague, Czech Republic): Widely used for peptide and small-molecule analysis. Known for accessibility and rapid turnaround. Offers HPLC, MS, and quantitative content testing.
• MZ Biolabs (United States): ISO 17025-accredited laboratory specializing in peptide and protein analysis. Comprehensive panel including amino acid analysis and endotoxin testing.
• Vanguard Analytical Labs: US-based independent testing facility offering HPLC, MS, and GC-MS residual solvent analysis.
• Eurofins Scientific: Large international testing network with extensive peptide analysis capabilities. Higher cost but broad accreditation scope.

ChemVerify aggregates and cross-references analytical data from independent laboratories to build a comprehensive quality profile for each vendor and product batch. When a vendor submits a Certificate of Analysis, ChemVerify compares the reported HPLC purity, mass spectral data, and content values against available third-party results for the same batch or equivalent production lots.

Discrepancies between vendor-reported and independently verified data are flagged and documented in the vendor quality profile. Consistent agreement increases a vendor trust score, while repeated discrepancies lower it. This systematic cross-referencing provides researchers with an objective, data-driven basis for vendor selection.

Independent peptide testing typically costs between $50 and $200 per sample depending on the analytical panel requested. Basic HPLC purity analysis is the most affordable option, while comprehensive panels including MS, AAA, and endotoxin testing are more expensive. Turnaround times range from 3-5 business days for standard service to 1-2 days for expedited analysis.

The submission process generally involves shipping a small sample (typically 5-10 mg of lyophilized peptide) to the laboratory with a test request form specifying the desired analyses. Results are delivered electronically as PDF reports with attached raw data files.

Is third-party testing required for all peptide research? While not legally required for most research applications, third-party verification is strongly recommended whenever experimental results depend on peptide identity and purity.

How often should researchers re-test peptide batches? Testing should be performed for each new batch. If working from a single batch over an extended period, re-testing after 6-12 months of storage can confirm that the peptide has not degraded.

Can third-party results differ from vendor CoA data? Yes. Method variability, instrument calibration differences, and sample handling can contribute to minor discrepancies of plus or minus 2-3% for HPLC purity. Larger discrepancies suggest genuine quality issues.